Credit Suisse Says Medivation Market Value Is Approaching its Target By: Benzinga via Benzinga July 07, 2016 at 08:11 AM EDT Medivation Inc (NASDAQ: MDVN) has rejected a hostile takeover bid by Sanofi SA (ADR) (NYSE: SNY) offering $58 per share in cash with ... Read More >> Related Stocks: Macy's Pfizer Sanofi-Aventis S.A. ADR